<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="117773">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02008669</url>
  </required_header>
  <id_info>
    <org_study_id>RC-P0022</org_study_id>
    <nct_id>NCT02008669</nct_id>
  </id_info>
  <brief_title>Evaluation of Nutritional Status and Fatigue in Patients With Multiple Sclerosis</brief_title>
  <acronym>NUTRISEP</acronym>
  <official_title>Evaluation of the Nutritional Status of Patients With Multiple Sclerosis and Relationship With Fatigue</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lille Catholic University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lille Catholic University</source>
  <oversight_info>
    <authority>France: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multiple sclerosis (MS) is a chronic progressive neurological disease, the leading cause of
      disability after injury accidents in young adults. Among the many symptoms, fatigue is very
      common with a significant impact on quality of life. Also, the disability caused by multiple
      sclerosis can alter food intake and can cause nutritional deficiencies. Nutrients such as
      proteins, minerals (iron, calcium, magnesium), some vitamins (B12, 25 OHD) are often
      deficient in this population with consequences in physical performance such as endurance and
      muscle strength. We propose to study the link between fatigue and shortcomings encountered
      in a defined population of MS patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Correlation between the score of fatigue EMIF-SEP and the dosage of nutrients in blood (vitamins, minerals, proteins) adjusted by the EDSS status</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>The objective is to construct and validate a regression model between the scale of fatigue and biological variables</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Presence or absence of sociodemographic variables</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence or absence of clinical manifestations</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of physical activity and daily energy expenditure</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assesment of dysphagia according to the score of the Dymmus Test</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Score of the taste sensibility test</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Score of the Beck depression inventory test</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>This test is a 21-question multiple-choice self-report inventory for measuring the severity of depression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Score of the visual analog scale for the evaluation of sleep quality</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Score of the Nutrition and Eating Habits Questionnaire</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">360</enrollment>
  <condition>Multiple Sclerosis</condition>
  <arm_group>
    <arm_group_label>Multiple Sclerosis cases</arm_group_label>
    <description>All patients will undergo the following interventions
Gustatory sensitivity test using Taste strips
Blood sampling
Questionnaires</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Blood sampling</intervention_name>
    <description>A blood sample will be taken from each patient and the following parameters will be assessed : magnesium, albumin, Vitamin B12, Vitamin D, Calcium, Iron.</description>
    <arm_group_label>Multiple Sclerosis cases</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Gustatory sensitivity test using Taste strips</intervention_name>
    <description>16 Taste Strips impregnated with 4 flavors (sweet, sour, salty, bitter, each flavor present at 4 different concentrations),  are offered to the patient one after the other in a so-called pseudorandomized sequence. The task of the patient is to choose one of the following answers: sweet / sour / salty / bitter / no taste.
Each correct answer is granted one point. In addition to the impregnated strips, two tasteless strips can be integrated in the examination at any point of time (no point)</description>
    <arm_group_label>Multiple Sclerosis cases</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaires</intervention_name>
    <description>Evaluation of the following parameters by validated questionnaires (name of the questionnaire in bracket):
Fatigue (EMIF-SEP)
Dysphagia (DYMUS)
Food intake (semi-structured questionnaire)
Depression (BDI-II)
Daily energy expenditure (NAP)
Visual analog scale to study quality of sleep</description>
    <arm_group_label>Multiple Sclerosis cases</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Biological analysis in serum: magnesium, albumin, Vitamin B12, Vitamin D, Calcium, Iron.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with MS defined according to the revised diagnostic criteria of Mac Donald, with
        ages between 18 to 65 years with an Expended disability status scale (EDSS) between 0 and
        7 and followed in the services of neurology or physical medicine and rehabilitation.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients between 18 and 65 years old

          -  Expended disability status scale (EDSS) between 0 and 7

          -  Diagnosis of MS according to the revised criteria of McDonald

          -  Clinically stable patients in the past 3 months

          -  Coverage of the social insurance

          -  Informed consent to participate

        Exclusion Criteria:

          -  Cognitive disorders that can hinder answering questionnaires

          -  Presence of uncontrolled metabolic disease(s)

          -  Malabsorption

          -  Patients with a gastrostomy

          -  Active cancer under treatment

          -  Anorexia

          -  Pregnancy or breast feeding

          -  Severe psychiatric disorder(s)

          -  No informed consent to participate

          -  No coverage by the social insurance
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cécile Donzé, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Groupement des Hôpitaux de l'Institut Catholique de Lille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean Jacques Vitagliano, PhD, CTC</last_name>
    <phone>+33 3 20 44 71 28</phone>
    <email>Vitagliano.Jean-Jacques@ghicl.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gabriela Certad, MD, PhD</last_name>
    <phone>+33 3 20 22 52 69</phone>
    <email>certad.gabriela@ghicl.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Caen</name>
      <address>
        <city>Caen</city>
        <state>Basse-Normandie</state>
        <zip>14033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Gilles Defer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier d'Arras</name>
      <address>
        <city>Arras</city>
        <state>Nord Pas-de-Calais</state>
        <zip>62022</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Patrick Le Coz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Boulogne, Hôpital Duchenne</name>
      <address>
        <city>Boulogne sur Mer</city>
        <state>Nord Pas-de-Calais</state>
        <zip>62200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Philippe Devos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Calais</name>
      <address>
        <city>Calais</city>
        <state>Nord Pas-de-Calais</state>
        <zip>62100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Olivier Dereeper, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Régional Universitaire de Lille</name>
      <address>
        <city>Lille</city>
        <state>Nord Pas-de-Calais</state>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Patrick Vermersch, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Groupement des Hôpitaux de l'Institut Catholique de Lille</name>
      <address>
        <city>Lille</city>
        <state>Nord Pas-de-Calais</state>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Cécile Donzé, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Arnaud Kwiatkowski, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charlotte Crinquette, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hichem Khenioui, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patrick Hautecoeur, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Sambre-Avenois</name>
      <address>
        <city>Maubeuge</city>
        <state>Nord Pas-de-Calais</state>
        <zip>59600</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Thierry Rosolacci, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Veronique Neuville, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hélène Borel</name>
      <address>
        <city>Raimbeaucourt</city>
        <state>Nord Pas-de-Calais</state>
        <zip>59283</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Brigitte Dubus, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Dron de Tourcoing</name>
      <address>
        <city>Tourcoing</city>
        <state>Nord Pas-de-Calais</state>
        <zip>59208</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Didier Ferriby, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Valenciennes</name>
      <address>
        <city>Valenciennes</city>
        <state>Nord Pas-de-Calais</state>
        <zip>59322</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Albert Verier, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire d'Amiens</name>
      <address>
        <city>Amiens</city>
        <state>Picardie</state>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Abdullatif Al Khedr, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 23, 2014</lastchanged_date>
  <firstreceived_date>December 3, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Multiple Sclerosis, Fatigue, Nutritional Status, Disability.</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fatigue</mesh_term>
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
